Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy

NCT02517502 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cognitive Dysfunction

Interventions

DRUG: DHA
DRUG: Placebo

Sponsor

Carol Fabian, MD

Collaborators

[object Object]